GELSOMINO, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 4.075
AS - Asia 2.075
EU - Europa 2.050
SA - Sud America 300
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 8.568
Nazione #
US - Stati Uniti d'America 3.977
SG - Singapore 643
IT - Italia 624
CN - Cina 585
GB - Regno Unito 389
VN - Vietnam 247
HK - Hong Kong 229
BR - Brasile 220
FI - Finlandia 171
SE - Svezia 159
DE - Germania 150
RU - Federazione Russa 113
FR - Francia 112
UA - Ucraina 73
IE - Irlanda 64
IN - India 61
KR - Corea 58
ID - Indonesia 56
CA - Canada 48
TR - Turchia 36
MX - Messico 34
AR - Argentina 31
LT - Lituania 30
BG - Bulgaria 26
JP - Giappone 26
BD - Bangladesh 24
ZA - Sudafrica 24
ES - Italia 21
AT - Austria 20
NL - Olanda 20
PL - Polonia 20
IQ - Iraq 16
EC - Ecuador 13
VE - Venezuela 13
CZ - Repubblica Ceca 12
AE - Emirati Arabi Uniti 11
BE - Belgio 11
PK - Pakistan 10
UZ - Uzbekistan 10
CH - Svizzera 9
PY - Paraguay 8
AZ - Azerbaigian 7
JO - Giordania 7
TN - Tunisia 7
MY - Malesia 6
NP - Nepal 6
AU - Australia 5
EU - Europa 5
KE - Kenya 5
PH - Filippine 5
CL - Cile 4
DK - Danimarca 4
EG - Egitto 4
IR - Iran 4
MA - Marocco 4
PE - Perù 4
RO - Romania 4
AL - Albania 3
CO - Colombia 3
CY - Cipro 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
NG - Nigeria 3
PA - Panama 3
PT - Portogallo 3
UG - Uganda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
JM - Giamaica 2
LB - Libano 2
OM - Oman 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AN - Antille olandesi 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
GT - Guatemala 1
KH - Cambogia 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
PS - Palestinian Territory 1
Totale 8.561
Città #
Ashburn 528
Santa Clara 422
Singapore 400
Fairfield 395
Chandler 254
Hong Kong 226
Woodbridge 196
Southend 182
San Jose 181
Hefei 160
Helsinki 149
Seattle 149
Houston 145
Wilmington 133
Cambridge 127
Nyköping 116
London 97
Beijing 90
Ho Chi Minh City 83
Shanghai 79
New York 76
Los Angeles 74
Dearborn 73
Ann Arbor 71
Council Bluffs 67
Dublin 61
Seoul 57
Hanoi 50
Jacksonville 46
Chicago 45
Jakarta 45
Modena 45
San Diego 44
Lauterbourg 36
The Dalles 32
Milan 31
Munich 30
Princeton 27
Dong Ket 26
Moscow 25
Orem 25
Sofia 25
São Paulo 24
Buffalo 23
Rome 23
Tokyo 23
Bologna 22
Izmir 21
Salt Lake City 19
Atlanta 18
Bremen 18
Johannesburg 18
Florence 17
Eugene 16
Ottawa 16
Warsaw 16
Dallas 15
Falls Church 13
Frankfurt am Main 13
Poplar 13
Siena 13
Turku 13
Brooklyn 12
Reggio Emilia 12
Stockholm 12
Kent 11
Manchester 11
Mexico City 11
Redwood City 11
Brussels 10
Denver 10
Des Moines 10
Naples 10
Parma 10
Phoenix 10
Redondo Beach 10
Brno 9
Düsseldorf 9
Hyderabad 9
Montreal 9
Nuremberg 9
Toronto 9
Vienna 9
Baghdad 8
Boston 8
Chennai 8
Guangzhou 8
Haiphong 8
Tampa 8
Amsterdam 7
Brasília 7
Da Nang 7
Elk Grove Village 7
Mumbai 7
Napoli 7
Portsmouth 7
Querétaro 7
Washington 7
Amman 6
Chieti 6
Totale 5.813
Nome #
Mutazioni somatiche di BRAF in pazienti affetti da melanoma maligno metastatico ed efficacia clinica degli approcci terapeutici a bersaglio molecolare con inibitori di BRAF 595
A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study) 402
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study 333
The evolving role of microsatellite instability in colorectal cancer: A review 324
Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion 319
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 315
Il trattamento di prima e seconda linea nel carcinoma gastrico 299
Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanomas 295
Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST 276
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 270
The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women 267
Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: A detailed clinical, pathologic, and molecular characterization 244
Immune-inflammatory and clinicopathologic prognostic factors in a Western cohort of resected gastric cancers (GCs) 242
Erratum: Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanoma (Disease Markers) 241
Impact of second-line cetuximab-containing therapy in patients with KRAS wild-type metastatic colorectal cancer: Results from the ITACa randomized clinical trial 238
Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial 236
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study 235
Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study 232
A user-friendly nomogram to predict relapse-free survival (RFS) in western patients with resected gastric cancer (GC) 228
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience. 220
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy 213
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center 210
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice 205
The growing skyline of advanced hepatocellular carcinoma treatment: A review. 203
Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST 202
BRAF-mutated colorectal cancer: Clinical and molecular insights 200
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study 183
Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters 175
Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma 159
Hereditary Micro‑Satellite Instable cancers associated with Lynch Syndrome: predictive biomarkers and novel immuno-therapeutic approaches 146
The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis 135
Early Onset Metastatic Colorectal Cancer: Current Insights and Clinical Management of a Rising Condition 135
mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus 128
Homologous recombination deficiency in pancreatic neuroendocrine tumors 125
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy 124
Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience 107
Spontaneous Regression of an Inflammatory Myofibroblastic Tumor: A Case Report and a Review of the Literature 100
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study 89
Totale 8.650
Categoria #
all - tutte 32.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.749


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021227 0 0 0 0 0 0 0 0 0 84 86 57
2021/2022633 49 44 30 19 32 57 18 43 60 88 137 56
2022/2023723 80 94 55 76 82 95 13 56 103 22 27 20
2023/2024499 7 26 36 70 66 54 52 61 5 10 54 58
2024/20251.674 56 15 27 108 288 232 144 103 198 91 134 278
2025/20263.021 272 126 216 395 513 238 465 190 282 324 0 0
Totale 8.650